| Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection G Cammarota, L Masucci, G Ianiro, S Bibbò, G Dinoi, G Costamagna, ... Alimentary pharmacology & therapeutics 41 (9), 835-843, 2015 | 665 | 2015 |
| The role of diet on gut microbiota composition. S Bibbo, G Ianiro, V Giorgio, F Scaldaferri, L Masucci, A Gasbarrini, ... European Review for Medical & Pharmacological Sciences 20 (22), 2016 | 400 | 2016 |
| The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy G Cammarota, G Ianiro, R Cianci, S Bibbò, A Gasbarrini, D Currò Pharmacology & therapeutics 149, 191-212, 2015 | 218 | 2015 |
| Gut microbiota modulation: probiotics, antibiotics or fecal microbiota transplantation? G Cammarota, G Ianiro, S Bibbò, A Gasbarrini Internal and emergency medicine 9, 365-373, 2014 | 185 | 2014 |
| Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders D Currò, G Ianiro, S Pecere, S Bibbò, G Cammarota British Journal of Pharmacology 174 (11), 1426-1449, 2017 | 181 | 2017 |
| Gut barrier in health and disease: focus on childhood. D Viggiano, G Ianiro, G Vanella, S Bibbò, G Bruno, G Simeone, G Mele European Review for Medical & Pharmacological Sciences 19 (6), 2015 | 174 | 2015 |
| Systematic review: sprue‐like enteropathy associated with olmesartan G Ianiro, S Bibbò, M Montalto, R Ricci, A Gasbarrini, G Cammarota Alimentary pharmacology & therapeutics 40 (1), 16-23, 2014 | 165 | 2014 |
| The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial V Ojetti, G Ianiro, A Tortora, G D’Angelo, TA Di Rienzo, S Bibbò, ... J Gastrointestin Liver Dis 23 (4), 387-91, 2014 | 148 | 2014 |
| Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic G Ianiro, BH Mullish, CR Kelly, Z Kassam, EJ Kuijper, SC Ng, TH Iqbal, ... Gut 69 (9), 1555-1563, 2020 | 142 | 2020 |
| Fecal microbiota transplantation in inflammatory bowel disease: beyond the excitement G Ianiro, S Bibbo, F Scaldaferri, A Gasbarrini, G Cammarota Medicine 93 (19), e97, 2014 | 126 | 2014 |
| Incidence of deep vein thrombosis among non‐ICU patients hospitalized for COVID‐19 despite pharmacological thromboprophylaxis A Santoliquido, A Porfidia, A Nesci, G De Matteis, G Marrone, E Porceddu, ... Journal of Thrombosis and Haemostasis 18 (9), 2358-2363, 2020 | 121 | 2020 |
| Is there a role for gut microbiota in type 1 diabetes pathogenesis? S Bibbò, MP Dore, GM Pes, G Delitala, AP Delitala Annals of medicine 49 (1), 11-22, 2017 | 110 | 2017 |
| Therapeutic modulation of gut microbiota: current clinical applications and future perspectives G Ianiro, S Bibbo, A Gasbarrini, G Cammarota Current drug targets 15 (8), 762-770, 2014 | 109 | 2014 |
| Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases G Ianiro, M Punčochář, N Karcher, S Porcari, F Armanini, F Asnicar, ... Nature Medicine 28 (9), 1913-1923, 2022 | 101 | 2022 |
| Gut microbiota as a driver of inflammation in nonalcoholic fatty liver disease S Bibbò, G Ianiro, MP Dore, C Simonelli, EE Newton, G Cammarota Mediators of inflammation 2018, 2018 | 97 | 2018 |
| Fecal microbiota transplantation: screening and selection to choose the optimal donor S Bibbò, CR Settanni, S Porcari, E Bocchino, G Ianiro, G Cammarota, ... Journal of Clinical Medicine 9 (6), 1757, 2020 | 92 | 2020 |
| Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year, single-centre cohort study G Ianiro, L Valerio, L Masucci, S Pecere, S Bibbò, G Quaranta, ... Clinical Microbiology and Infection 23 (5), 337. e1-337. e3, 2017 | 92 | 2017 |
| Liver involvement is not associated with mortality: results from a large cohort of SARS‐CoV‐2‐positive patients FR Ponziani, F Del Zompo, A Nesci, F Santopaolo, G Ianiro, M Pompili, ... Alimentary pharmacology & therapeutics 52 (6), 1060-1068, 2020 | 84 | 2020 |
| Predicting in‐hospital mortality in COVID‐19 older patients with specifically developed scores M Covino, G De Matteis, ML Burzo, A Russo, E Forte, A Carnicelli, ... Journal of the American Geriatrics Society 69 (1), 37-43, 2021 | 76 | 2021 |
| Levothyroxine absorption in health and disease, and new therapeutic perspectives. G Ianiro, F Mangiola, TA Di Rienzo, S Bibbò, F Franceschi, AV Greco, ... European Review for Medical & Pharmacological Sciences 18 (4), 2014 | 76 | 2014 |
